GSK raises £886m after offloading chunk of Haleon shares October 6, 2023 GSK has pocketed £886m after offloading a chunk of its stake in the spun off consumer healthcare arm Haleon, the firm announced this morning. The FTSE 100 healthcare giant announced yesterday that it would sell some 270m in ordinary shares at a price of 328p per share. The sale has now slashed the size of [...]
GSK: British drugmaker raises profit and sales guidance after earnings beat expectations July 26, 2023 GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines. The strong results may further help revive investor confidence in CEO Emma Walmsley, coming a year after the company spun off its consumer health business, Haleon, in its most [...]
GSK settles lawsuit over heartburn drug Zantac with alleged cancer links but ‘admits no liability’ June 23, 2023 Pharmaceutical giant GSK has revealed it has settled a lawsuit relating to discontinued heartburn drug Zantac, which was alleged to be linked to cancer. Shares in GSK jumped after it said an upcoming trial was cancelled but that it does not admit liability. The company hit back at allegations last year that the use of [...]
GSK offloads £804m worth of shares in spun out healthcare arm Haleon May 12, 2023 British drugmaker GlaxoSmithKline (GSK) has today offloaded some 240m shares of its spun out consumer healthcare group Haleon in a move which has raised £804m for the firm.
Haleon: Flu season and Chinese pain relief give GSK spin-out a boost May 3, 2023 A “strong” cold and flu season and the end of Chinese lockdowns contributed to a healthy revenue boost for Haleon, the spin-out of GSK’s consumer healthcare division. Organic revenues within the group were up 9.9 per cent, with operating profit hitting £627m – reflecting a large reduction in the costs of spinning out the business [...]
GSK brings in zosta lot more cash as drugs giant’s turnover boosted by shingles vaccine and HIV medicines April 26, 2023 Drugs giant GSK has posted better-than-forecast revenues for the first quarter thanks to strong sales of its shingles vaccine and HIV medicines. The FTSE 100 group saw earnings fall 15 per cent on a constant currency basis to £2.1bn in the first quarter as revenues dropped eight per cent to £7bn after sales of its Covid-19 treatment [...]
GSK: Hundreds of workers at British pharma giant to strike in May in pay dispute April 19, 2023 Hundreds of workers at pharmaceutical giant GSK will stage a series of walkouts in May in a dispute over pay. Unite said 750 of its members have voted for strike action after rejecting a 6% pay offer and a one-off lump sum of £1,300, describing it as “significantly below” inflation. Unite said industrial action will [...]
GSK coughs up £1.6bn for Bellus as pharma giant boosts its patent medicine cabinet April 18, 2023 GSK plans to buy developer Bellus Health in an all-cash deal for £1.6bn as the drugmaker expands its bet on respiratory therapies.
Shingles vaccine gives GSK a shot in the arm – as Haleon demerger nets £10.1bn gain February 1, 2023 Pharma giant GSK recorded what Dame Emma Walmsley called a "landmark" year with vaccine sales driven up significantly
GSK and Sanofi shares jump with investor fears soothed by Zantac ruling December 7, 2022 Shares in GlaxoSmithKline (GSK) and Sanofi jumped today, after thousands of claims apart of the Zantac lawsuit were dismissed. Investors’ fears were soothed yesterday when US district judge Robin Rosenberg rejected 50,000 claims in federal court for not being based on sound science. GSK’s shares jumped around eight per cent to 1,498.00p per share in [...]